Drugs.com
Comprehensive drug information, interactions, and side effect database for GLP-1 medications
Official Novo Nordisk resource for Ozempic semaglutide information and support
The official Novo Nordisk site for Ozempic, semaglutide administered as a weekly injection. One distinction matters more than any other on this page: Ozempic is FDA approved to improve blood sugar control in adults with type 2 diabetes and to reduce cardiovascular risk in that population, not as a weight loss drug. Weight loss is a documented effect, and prescribing it for that purpose is off-label. The site carries prescribing information, dosing schedules, and savings details.
Comprehensive drug information, interactions, and side effect database for GLP-1 medications
Medical reference and drug information for patients researching GLP-1 medications
Official Novo Nordisk resource for Wegovy weight management information